- Home
- COTY vs ROIV Comparison
COTY vs ROIV Comparison
Compare COTY & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COTY
- ROIV
- Stock Information
- Founded
- COTY 1904
- ROIV 2014
- Country
- COTY United States
- ROIV United Kingdom
- Employees
- COTY N/A
- ROIV N/A
- Industry
- COTY Package Goods/Cosmetics
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- COTY Consumer Discretionary
- ROIV Health Care
- Exchange
- COTY Nasdaq
- ROIV Nasdaq
- Market Cap
- COTY 3.5B
- ROIV 8.6B
- IPO Year
- COTY 2013
- ROIV N/A
- Fundamental
- Price
- COTY $4.32
- ROIV $15.28
- Analyst Decision
- COTY Hold
- ROIV Strong Buy
- Analyst Count
- COTY 17
- ROIV 4
- Target Price
- COTY $5.77
- ROIV $15.50
- AVG Volume (30 Days)
- COTY 13.2M
- ROIV 7.8M
- Earning Date
- COTY 11-05-2025
- ROIV 11-11-2025
- Dividend Yield
- COTY N/A
- ROIV N/A
- EPS Growth
- COTY N/A
- ROIV N/A
- EPS
- COTY N/A
- ROIV N/A
- Revenue
- COTY $5,892,900,000.00
- ROIV $23,233,000.00
- Revenue This Year
- COTY $1.27
- ROIV N/A
- Revenue Next Year
- COTY $2.63
- ROIV $281.14
- P/E Ratio
- COTY N/A
- ROIV N/A
- Revenue Growth
- COTY N/A
- ROIV N/A
- 52 Week Low
- COTY $3.67
- ROIV $8.73
- 52 Week High
- COTY $9.70
- ROIV $16.05
- Technical
- Relative Strength Index (RSI)
- COTY 48.52
- ROIV 82.00
- Support Level
- COTY $4.01
- ROIV $13.81
- Resistance Level
- COTY $4.24
- ROIV $14.48
- Average True Range (ATR)
- COTY 0.16
- ROIV 0.47
- MACD
- COTY 0.03
- ROIV 0.22
- Stochastic Oscillator
- COTY 56.35
- ROIV 81.67
About COTY Coty Inc.
Coty is a global beauty maker that generates 65% of sales from prestige beauty products (primarily fragrances) and 35% from mass makeup, skin care, and fragrance. For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein. In contrast, its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrity Kylie Jenner to manage makeup products bearing her name. By region, Coty generates close to 48% of sales from Europe, 40% from the Americas, and 12% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 54% stake as of June 2025.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.